BioNxt Solutions Inc. (CVE:BNXT) | WebDisclosure

Basculer en Français

10355	Companies
215502	Keywords
145322	Articles
114166	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

PRESS RELEASE

published on 02/27/2026 at 01:00, 2 months 8 days ago

BioNxt Announces Closing of Shares for Debt Settlement
BioNxt Solutions Inc. settles $2.7M debt with 6,008,883 common shares. Compensation shares issued to Canaccord Genuity Corp. for facilitating the debt settlement. Company focuses on drug delivery tech and pharmaceutical development

Common Shares Debt Settlement BioNxt Solutions Inc. Drug Delivery Pharmaceutical Development
BRIEF

published on 02/17/2026 at 09:10, 2 months 17 days ago

BioNxt obtient un brevet européen pour sa technologie de cladribine sublinguale

Sclérose En Plaques Solutions BioNxt Brevet Européen Administration De Médicaments Technologie Sublinguale
BRIEF

published on 02/17/2026 at 09:10, 2 months 17 days ago

BioNxt Secures European Patent for Sublingual Cladribine Technology

Multiple Sclerosis Drug Delivery European Patent BioNxt Solutions Sublingual Technology
PRESS RELEASE

published on 02/17/2026 at 09:05, 2 months 17 days ago

BioNxt Receives Milestone EPO Decision to Grant European Patent for Sublingual Cladribine Drug Delivery Technology for Multiple Sclerosis
BioNxt Solutions Inc. receives European Patent No. 4539857 for sublingual cladribine oral thin film drug delivery tech, advancing global IP rights in pharmaceutical sector

Pharmaceutical BioNxt Solutions Inc. Cladribine Drug Delivery European Patent
BRIEF

published on 02/05/2026 at 09:10, 3 months 1 day ago

BioNxt Solutions Secures Chaperone Technology to Advance Oral Drug Delivery

Drug Delivery BioNxt Solutions Neurological Diseases Chaperone Technology Oral Dissolvable Films
BRIEF

published on 02/05/2026 at 09:10, 3 months 1 day ago

BioNxt Solutions acquiert une technologie chaperonne pour faire progresser l'administration orale de médicaments

Solutions BioNxt Administration De Médicaments Maladies Neurologiques Technologie Des Chaperons Films Orodispersibles
PRESS RELEASE

published on 02/05/2026 at 09:05, 3 months 1 day ago

BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
BioNxt Solutions Inc. announced signing a letter of intent for exclusive rights to advanced drug chaperone technology, enhancing its oral dissolvable thin-film platform

BioNxt Solutions Inc. Letter Of Intent Drug Chaperone Technology Oral Dissolvable Thin-film Biotechnology Developer
BRIEF

published on 01/26/2026 at 09:10, 3 months 11 days ago

BioNxt Advances Cladribine ODF for Multiple Sclerosis and Myasthenia Gravis

Multiple Sclerosis Drug Delivery Cladribine ODF Myasthenia Gravis BioNxt
BRIEF

published on 01/26/2026 at 09:10, 3 months 11 days ago

BioNxt fait progresser la cladribine ODF pour la sclérose en plaques et la myasthénie grave

Sclérose En Plaques Cladribine ODF Myasthénie Grave Administration De Médicaments BioNxt
PRESS RELEASE

published on 01/26/2026 at 09:05, 3 months 11 days ago

BioNxt Accelerates ODF for Multiple Sclerosis Toward Human Clinical Study with >40% Bioavailability Improvement and Myasthenia Gravis Expansion
BioNxt announces progress in cladribine oral thin film development, with focus on bioavailability improvement and human clinical study for Multiple Sclerosis. Expansion into Myasthenia Gravis also planned

Multiple Sclerosis Cladribine Myasthenia Gravis BioNxt Oral Thin Film

Accesswire

Published on 05/07/2026 at 02:00, 5 minutes ago

Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 2 hours 35 minutes ago

Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 3 hours ago

Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 3 hours 5 minutes ago

Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/06/2026 at 22:10, 3 hours 55 minutes ago

Banyan Gold Announces Closing of $46.5 Million Private Placement

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 00:47, 1 hour 18 minutes ago

Blue Cap AG expands portfolio through the acquisition of Janoschka AG
Published on 05/07/2026 at 00:43, 1 hour 21 minutes ago

EQS-Adhoc: Blue Cap AG Acquires Janoschka AG and Adjusts Forecast Due to Transaction
Published on 05/06/2026 at 20:32, 5 hours 33 minutes ago

EQS-Adhoc: Kontron AG: ADHOC Kontron AG / Potential Public Takeover Bid by Ennoconn Corporation
Published on 05/06/2026 at 20:22, 5 hours 43 minutes ago

EQS-Adhoc: ams-OSRAM AG: ams OSRAM delivers strong Q1 results, enters AI market through a development agreement with a leading AI photonics customer and sees path to positive Free Cash Flow in 2027
Published on 05/06/2026 at 19:18, 6 hours 47 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/06/2026 at 18:00, 8 hours 4 minutes ago

Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 8 hours 4 minutes ago

Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 8 hours 5 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 18:00, 8 hours 5 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
Published on 05/06/2026 at 17:45, 8 hours 20 minutes ago

Information concerning the total number of voting rights and shares 2026 04 30

View all LES ECHOS COMFI WIRE